Artificial intelligence in urologic oncology: the actual clinical practice results of IBM Watson for Oncology in South Korea [0.03%]
泌尿肿瘤学中的人工智能：IBM沃森在韩国实际临床结果
Taeyoung Park,Philip Gu,Chang-Hee Kim et al.
Taeyoung Park et al.
Background: Artificial intelligence (AI) is changing our life, including the medical field. Repeated machine learning using big data made various fields more predictable and accurate. In medicine, IBM Watson for Oncology ...
Developing an AI-Assisted Educational Chatbot for Radiotherapy Using the IBM Watson Assistant Platform [0.03%]
基于IBM Watson Assistant平台的放射治疗辅助教育聊天机器人开发
James C L Chow,Valerie Wong,Leslie Sanders et al.
James C L Chow et al.
Objectives: This study aims to make radiotherapy knowledge regarding healthcare accessible to the general public by developing an AI-powered chatbot. The interactive nature of the chatbot is expected to facilitate better understanding of in...
IBM WATSON Trauma Pathway Explorer© as a Predictor for Sepsis after Polytrauma - Is Procalcitonin Useful for Identifying Septic Polytrauma Patients? [0.03%]
IBM WATSON创伤途径探索器©作为多发伤后败血症的预测指标-プロカルシトニン对识别败血症多发伤患者有用吗？
Cédric Niggli,Philipp Vetter,Jan Hambrecht et al.
Cédric Niggli et al.
IBM and the University Hospital Zurich have developed an online tool for predicting outcomes of a patient with polytrauma, the IBM WATSON Trauma Pathway Explorer® . The three predicted outcomes are Systemic Inflammatory Response Syndrome (...
The Role of Lactate for Sepsis in Polytrauma Patients, a Time related Analysis using the IBM Watson Trauma Pathway Explorer® [0.03%]
乳酸在多发伤患者脓毒症中的作用：使用IBM watson创伤路径 explorer®进行的时间相关分析
Philipp Vetter,Cédric Niggli,Jan Hambrecht et al.
Philipp Vetter et al.
The Watson Trauma Pathway Explorer ® is an outcome prediction tool invented by the University Hospital of Zurich in collaboration with IBM®, representing an artificial intelligence application to predict the most adverse outcome scenarios...
Identification of glomerulosclerosis using IBM Watson and shallow neural networks [0.03%]
利用IBM Watson和浅层神经网络进行系膜增生性肾炎的识别
Francesco Pesce,Federica Albanese,Davide Mallardi et al.
Francesco Pesce et al.
Background: Advanced stages of different renal diseases feature glomerular sclerosis at a histological level which is observed by light microscopy on tissue samples obtained by performing a kidney biopsy. Computer-aided d...
New Time-Related Insights into an Old Laboratory Parameter: Early CRP Discovered by IBM Watson Trauma Pathway Explorer© as a Predictor for Sepsis in Polytrauma Patients [0.03%]
一个新的实验室参数的时间相关新见解：IBMWatson创伤路径探测器发现早期CRP可作为多发伤病人脓毒症的预测因素
Ladislav Mica,Hans-Christoph Pape,Philipp Niggli et al.
Ladislav Mica et al.
The University Hospital Zurich together with IBM® invented an outcome prediction tool based on the IBM Watson technology, the Watson Trauma Pathway Explorer®. This tool is an artificial intelligence to predict three outcome scenarios in p...
Keratoconus-susceptibility gene identification by corneal thickness genome-wide association study and artificial intelligence IBM Watson [0.03%]
通过角膜厚度全基因组关联研究和人工智能IBM沃森鉴定出易感圆锥角膜的基因
Yoshikatsu Hosoda,Masahiro Miyake,Akira Meguro et al.
Yoshikatsu Hosoda et al.
Keratoconus is a common ocular disorder that causes progressive corneal thinning and is the leading indication for corneal transplantation. Central corneal thickness (CCT) is a highly heritable characteristic that is associated with keratoc...
Application of IBM Watson to Support Literature Reviews: A Preliminary Experience in Restorative Dentistry [0.03%]
IBM Watson支持文献回顾的应用——修复牙科学的初步尝试与体验分析
Giacomo Derchi,Marco Visentin,Vincenzo Marchio et al.
Giacomo Derchi et al.
Literature reviews are crucial in the choice of the best personalized material type and restauration type in restorative dentistry. We developed an IBM-Watson based system to support literature search for restorative dentistry, and compared...
Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in China [0.03%]
IBM Watson for Oncology与我国多学科肿瘤诊疗组在乳腺癌治疗建议方面的一致性分析
Xiaoyao Zhao,Yinbin Zhang,Xingcong Ma et al.
Xiaoyao Zhao et al.
Objective: Watson for Oncology (WFO), an artificial intelligence from IBM Corporation, can provide a treatment plan by analyzing patient's disease characteristics. The present study was performed to examine the concordanc...
Concordance Study Between IBM Watson for Oncology and Real Clinical Practice for Cervical Cancer Patients in China: A Retrospective Analysis [0.03%]
IBM Watson肿瘤与中国宫颈癌患者临床实践一致性研究：回顾性分析
Fang-Wen Zou,Yi-Fang Tang,Chao-Yuan Liu et al.
Fang-Wen Zou et al.
Watson for Oncology (WFO) is a artificial intelligence clinical decision-support system with evidence-based treatment options for oncologists. WFO has been gradually used in China, but limited reports on whether WFO is suitable for Chinese ...
耗时 0.09826 秒，为您在
48770473
条记录里面共找到 28 篇文章 [XML]